Trademark: 97042705
Status Date
Tuesday, February 27, 2024
Filing Date
Thursday, September 23, 2021
Published for Opposition
Tuesday, February 27, 2024
5 Hydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy
10 Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy
42 Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2024
Published For Opposition
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2024
Approved For Pub - Principal Register
Jan 24, 2024
Examiner's Amendment Entered
Jan 24, 2024
Notification Of Examiners Amendment E-Mailed
Jan 24, 2024
Examiners Amendment E-Mailed
Jan 24, 2024
Examiners Amendment -Written
Dec 28, 2023
Teas/Email Correspondence Entered
Dec 27, 2023
Correspondence Received In Law Office
Dec 27, 2023
Teas Response To Office Action Received
Oct 27, 2023
Teas Change Of Correspondence Received
Oct 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 27, 2023
Teas Change Of Owner Address Received
Aug 25, 2023
Application Extension Granted/Receipt Provided
Aug 25, 2023
Application Extension To Response Period - Received
Jun 30, 2023
Notification Of Non-Final Action E-Mailed
Jun 30, 2023
Non-Final Action E-Mailed
Jun 30, 2023
Non-Final Action Written
Jun 8, 2023
Suspension Checked - To Attorney For Action
Nov 25, 2022
Notification Of Letter Of Suspension E-Mailed
Nov 25, 2022
Letter Of Suspension E-Mailed
Nov 25, 2022
Suspension Letter Written
Nov 14, 2022
Examiner's Amendment Entered
Nov 14, 2022
Notification Of Examiners Amendment E-Mailed
Nov 14, 2022
Examiners Amendment E-Mailed
Nov 14, 2022
Examiners Amendment -Written
Oct 22, 2022
Teas/Email Correspondence Entered
Oct 21, 2022
Correspondence Received In Law Office
Oct 21, 2022
Teas Response To Office Action Received
Jul 21, 2022
Notification Of Non-Final Action E-Mailed
Jul 21, 2022
Non-Final Action E-Mailed
Jul 21, 2022
Non-Final Action Written
Jun 24, 2022
Assigned To Examiner
Nov 3, 2021
Automatic Update Of Assignment Of Ownership
Oct 26, 2021
New Application Office Supplied Data Entered
Sep 27, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
